A detailed history of High Tower Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, High Tower Advisors, LLC holds 1,026,756 shares of BMY stock, worth $54.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,026,756
Previous 1,225,231 16.2%
Holding current value
$54.6 Million
Previous $66.4 Million 35.82%
% of portfolio
0.07%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $7.99 Million - $10.5 Million
-198,475 Reduced 16.2%
1,026,756 $42.6 Million
Q1 2024

May 06, 2024

SELL
$47.98 - $54.4 $10.8 Million - $12.3 Million
-225,789 Reduced 15.56%
1,225,231 $66.4 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $6.43 Million - $7.67 Million
-132,566 Reduced 8.37%
1,451,020 $74.5 Million
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $3.11 Million - $3.47 Million
53,664 Added 3.51%
1,583,586 $91.9 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $3.79 Million - $4.21 Million
59,531 Added 4.05%
1,529,922 $97.8 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $5.23 Million - $5.93 Million
-79,588 Reduced 5.13%
1,470,391 $102 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $4.29 Million - $5.08 Million
62,674 Added 4.21%
1,549,979 $112 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $4,907 - $2.9 Million
-37,752 Reduced 2.48%
1,487,305 $106 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $2.95 Million - $3.25 Million
40,596 Added 2.73%
1,525,057 $117 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $2.56 Million - $3.07 Million
41,648 Added 2.89%
1,484,461 $108 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $4.26 Million - $4.96 Million
79,370 Added 5.82%
1,442,813 $89.9 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $4.01 Million - $4.7 Million
67,833 Added 5.24%
1,363,443 $80.7 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $3.82 Million - $4.16 Million
61,731 Added 5.0%
1,295,610 $86.5 Million
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $336,101 - $378,015
5,664 Added 0.46%
1,233,879 $77.9 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $92,730 - $105,080
-1,606 Reduced 0.13%
1,228,215 $76.2 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $4.22 Million - $4.68 Million
73,538 Added 6.36%
1,229,821 $74.1 Million
Q2 2020

Aug 10, 2020

SELL
$54.82 - $64.09 $2.04 Million - $2.38 Million
-37,177 Reduced 3.12%
1,156,283 $68 Million
Q1 2020

May 21, 2020

BUY
$46.4 - $67.43 $1.94 Million - $2.82 Million
41,806 Added 3.63%
1,193,460 $66.6 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $9.73 Million - $12.7 Million
197,645 Added 20.72%
1,151,654 $73.9 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $8.15 Million - $9.67 Million
190,626 Added 24.97%
954,009 $48.4 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $3.54 Million - $3.91 Million
-79,283 Reduced 9.41%
763,383 $34.6 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $4.95 Million - $5.9 Million
109,723 Added 14.97%
842,666 $40.2 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $2.08 Million - $2.7 Million
-42,746 Reduced 5.51%
732,943 $38.1 Million
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $2.32 Million - $2.62 Million
-42,066 Reduced 5.14%
775,689 $48.1 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $5.83 Million - $7.27 Million
-115,364 Reduced 12.36%
817,755 $45.3 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $8.51 Million - $9.8 Million
-142,073 Reduced 13.21%
933,119 $59 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $6.36 Million - $6.94 Million
-106,182 Reduced 8.99%
1,075,192 $65.8 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $1.75 Million - $2.02 Million
31,678 Added 2.76%
1,181,374 $75.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,149,696
1,149,696 $64.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.